Sleep and recovery
Sleep and recovery claims for CJC-1295
A preserved hormone rhythm sounds reassuring at bedtime. The actual sleep experiments introduce different substances, different subjects and a question running in the opposite direction.
The human GHRH sleep experiment
In Steiger and colleagues’ 1992 experiment, normal men received GHRH, the natural hormone that prompts GH release. Slow-wave sleep and nocturnal GH secretion increased. The investigators also examined somatostatin, which suppresses GH release. They measured sleep EEG, the record of electrical activity during sleep, alongside hormones.
I value the actual sleep measurements in this experiment. That is closer to the hoped-for benefit than a hormone concentration alone. But the administered substance was GHRH. A controlled human sleep trial of CJC-1295 would have to establish its own effects; the natural hormone’s result gives a reason to investigate.
Sleep-dependent GH release in mice
The 2025 sleep-circuit study examined a neuroendocrine circuit for sleep-dependent growth-hormone release in mice. Here sleep helps govern the hormone signal. That is a different question from whether administering CJC-1295 improves human sleep, and CJC-1295 was not the tested treatment.
The direction of the question matters to me. A connection between sleep and GH can invite an appealing story in either direction, yet each direction needs its own experiment. The CJC-1295 pulse study measured continuing GH pulses and higher basal secretion; it did not measure a better night’s rest.
Exercise recovery and healing
The familiar recovery argument runs through growth hormone, IGF-1 and tissue repair. The 2026 review of peptide therapies for musculoskeletal conditions addresses the evidence gaps around those treatment claims. Early human CJC-1295 studies did not establish faster injury healing or exercise recovery.
Some related metabolic research is even further away from that question. Aagaard and colleagues studied prednisolone-treated rats, examining nitrogen balance and urea synthesis after ipamorelin or GH. They tested those substances in rats, without testing CJC-1295 or human recovery.
Sleep and soreness also feature prominently in anecdotal online accounts. Those accounts describe experiences rather than clinical evidence. I’d welcome a direct trial that recorded people’s sleep or recovery alongside the hormone measurements. Until then, the basal GH result remains an intriguing physiological finding with its everyday value still open.